Why the study?
Does percutaneous aortic balloon valvuloplasty as a bridge to intervention improve survival in high-risk patients referred for TAVI?
Cohort (n=253)
Does percutaneous aortic balloon valvuloplasty as a bridge to intervention improve survival in high-risk patients referred for TAVI?
Answers are grounded in this paper and cite their sources.
PABV is a viable bridge to definitive TAVI or AVR in high-risk patients with temporary contraindications, achieving mid-term survival comparable to primary intervention.
AIMS: To assess the results of percutaneous aortic balloon valvuloplasty (PABV) as a potential bridge to further intervention in patients referred for transcatheter aortic valve implantation (TAVI). METHODS AND RESULTS: Two hundred and fifty-three patients referred for TAVI were studied: 41 (16%) were considered transiently unsuitable for either aortic valve replacement (AVR) or TAVI and underwent PABV as a bridge to intervention. In the others, primary TAVI or AVR was performed in 140 cases, and medical therapy alone in 72.The overall population was at high risk: 82 ± 8 years, logistic EuroSCORE: 28 ± 16%, STS score: 16 ± 10%. There was no PABV-related death. Twenty-three patients underwent secondary TAVI (n=19) or AVR (n=4), 18 did not undergo further intervention. One and two year survival rates were respectively 94 ± 5% and 85 ± 10% after bridge PABV, and 33 ± 11 and 6 ± 5% after PABV alone. There was no difference in survival between the primary TAVI / AVR and bridge PABV (p=0.08), and between medical treatment and PABV alone (p=0.36). CONCLUSION: In high-risk patients with aortic stenosis and temporary contraindications to AVR or TAVI, PABV may be used as a bridge to intervention with good mid-term outcomes. In others, PABV can be safely used but is associated with a poor outcome.
No takes yet. Share an insight, caveat, or question.
Tissot et al. (2011) conducted a cohort in Aortic stenosis (n=253). Percutaneous aortic balloon valvuloplasty (PABV) vs. Primary TAVI/AVR or medical therapy was evaluated on Survival (p=0.08).
Synapse has enriched 10 related papers. Consider them for comparative context: